Jiezhou Wu

860 citations
14 papers · 698 indexed · 1 hit paper · h-index 14
Topics
Hip and Femur Fractures (3 papers)Pelvic and Acetabular Injuries (3 papers)Bone Tissue Engineering Materials (2 papers)
Partner nations
ChinaMacao

In The Last Decade

Jiezhou Wu

14 papers receiving 692 citations

Hit Papers

Injectable Microfluidic Hydrogel Microspheres for Cell an...2021202620222024202150100150200

Peers

Jiezhou Wu
Comparison fields: 5 of 99
  • Biomedical Engineering 268
  • Surgery 261
  • Biomaterials 140
  • Epidemiology 138
  • Molecular Biology 89
Replace Yasuhiko Kasahara with:
Yasuhiko Kasahara Japan
Martine Renard France
Jiacheng Liu China
Shiyu Liu Canada
DaShawn A. Hickman United States
Yunsu Chen China
Anand P. Khandwekar India
Marbod Weber Germany
Masoud Eslami Iran
Jiezhou Wu relative to Yasuhiko Kasahara Japan Yasuhiko Kasahara's profile →
Citations per field
00.5×5.8×
Yasuhiko Kasahara · 1×
Citations per year

Countries citing papers authored by Jiezhou Wu

Since Specialization
Citations

This map shows the geographic impact of Jiezhou Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiezhou Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiezhou Wu more than expected).

Fields of papers citing papers by Jiezhou Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiezhou Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiezhou Wu. The network helps show where Jiezhou Wu may publish in the future.

Co-authorship network of co-authors of Jiezhou Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiezhou Wu. A scholar is included among the top collaborators of Jiezhou Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiezhou Wu. Jiezhou Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 15
2 19
3 26
4 57
5
Injectable Microfluidic Hydrogel Microspheres for Cell and Drug Deliverybreakdown →
226
6 114
7 13
8 13
9 19
10 38
11 31
12 25
13 75
14 27

About Jiezhou Wu

Jiezhou Wu is a scholar working on Applied Microbiology and Biotechnology, Rehabilitation and Internal Medicine, having authored 14 papers that have together received 698 indexed citations. Recurring topics across this work include Hip and Femur Fractures (3 papers), Pelvic and Acetabular Injuries (3 papers) and Bone Tissue Engineering Materials (2 papers). The work is most often cited by research in Molecular Medicine (79 citations), Biomaterials (140 citations) and Rehabilitation (47 citations). Jiezhou Wu has collaborated with scholars based in China and Macao. Frequent co-authors include Gen Li, Ming Cai, Wenguo Cui, Lianfu Deng, Ming Cai, Lei Wang, Zhenyu Zhao, Zhengwei Cai, Zhen Wang and Guanghua Lu. Their work appears in journals such as Advanced Functional Materials, Chemical Engineering Journal and BioMed Research International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026